[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:b-lymphoblastic-lymphoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":47,"states":52},"B Lymphoblastic Lymphoma",6,[7,15,21,28,35,41],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT02981628","Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia",[11],"Phase 2","RECRUITING","2026-08-03T00:52:47.662427Z","2026-07-05T05:32:16.771394Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT02877303","Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia",[11],"2026-08-26T02:18:05.435729Z","2026-05-05T02:43:29.482656Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":26,"content_modified":27},"NCT03959085","Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy",[25],"Phase 3","2026-08-26T02:18:17.950264Z","2026-07-05T03:45:20.447682Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":33,"content_modified":34},"NCT05442515","CD19\u002FCD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies",[32],"Phase 1\u002FPhase 2","2026-08-26T02:18:21.216897Z","2026-07-05T05:32:16.802455Z",{"nct_id":36,"title":37,"phases":38,"status":12,"updated_at":39,"content_modified":40},"NCT02393157","Obinutuzumab and ICE Chemotherapy in Refractory\u002FRecurrent CD20+ Mature NHL",[11],"2026-08-26T02:17:44.240289Z","2026-05-05T02:43:28.289405Z",{"nct_id":42,"title":43,"phases":44,"status":12,"updated_at":45,"content_modified":46},"NCT06710418","Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma\u002FLeukemia",[],"2026-08-26T02:18:37.277498Z","2026-05-05T02:43:27.808498Z",[48],{"biomarker":49,"count":50,"slug":51},"CD22 Gene",4,"cd22-gene",[53,57,60,63],{"state":54,"count":55,"slug":56},"Maryland",3,"maryland",{"state":58,"count":55,"slug":59},"New York","new-york",{"state":61,"count":55,"slug":62},"Texas","texas",{"state":64,"count":55,"slug":65},"Washington","washington"]